Answers are grounded in this paper and cite their sources.
A 9-year-old boy presented with a 3-year history of a persistent, slowly progressing, mildly pruritic and scaling rash on the right buttock and medial thighs bilaterally. His parents reported a partial clearance with a moderately potent topical steroid with a rapid rebound on discontinuation. He was otherwise well, the rash not being associated with systemic symptoms namely fever, weight loss or fatigue. There was no other relevant medical or family history of note. The physical examination revealed erythematous to purpuric, mild scaly patches with confluent involvement on the right buttock extending to less defined involvement of the both inner thighs (Figures 1 and 2). The body surface area involved was less than 10%. There was no appreciable lymphadenopathy or hepatosplenomegaly on clinical examination. A full blood count and lactate dehydrogenase were within normal ranges. Considering the atypical distribution of the rash in photo protected areas, a punch biopsy was performed for histopathology (Figures 3 and 4). Pigmented purpuric dermatosis-like mycosis fungoides (PPD-like MF) Histology revealed a band-like dermal infiltrate of lymphocytes with marked epidermotropism (Figure 3) and intraepidermal lymphocytic collections (Figure 4). Intraepidermal lymphocytes showed nuclear atypia and cerebriform nuclei. There were multiple extravasated red blood cells in the papillary dermis, however pigment and melanophages were not seen. Immunohistochemistry was CD45+, CD3+, CD7+, CD4+ and CD8+ with a CD4:CD8 ratio of approximately 1:1. CD20 was negative, as were CD30, CD56, ALK and TIA-1. A monoclonal T-cell population was detected. The patient responded well to a potent topical steroid (mometasone furoate) daily which was gradually tapered to twice weekly/intermittent usage to maintain response. Pigmented purpuric dermatosis-like mycosis fungoides (PPD-like MF) is a rare variant of paediatric mycosis fungoides (MF).1 Clinically, it can be challenging to diagnose and differentiate from pigmented purpuric dermatosis (PPD) which may be related to MF in three ways: (1) MF can present clinically as PPD, (2) PPD can precede MF, (3) PPD can resemble MF histologically.1 Paediatric MF accounts for only 4%–5% of all MF cases in USA and Europe.2, 3 MF has an indolent nature; however the diagnosis can be delayed due to misdiagnosis as inflammatory dermatoses.4 Poorer long-term prognosis is associated with delayed diagnosis.4 Hypopigmented MF is considered a typical form of childhood MF, especially among children with darker skin types. In addition to classical MF, other rare forms have been described including unilesional MF, PPD-like MF, granulomatous MF, ichthyosiform MF, pityriasis lichenoides-like MF, hyperpigmented MF, MF with large cell transformation and MF following organ transplantation.3 PPD-like MF is rarely described in the literature. From our review of published cases PPD-like MF represents less than 2% of all cases (Table 1). The MF lesions can occur on any area of the body, but often localise to sun-protected areas with three stages: patch, plaque, and tumour, characterised by variability in the size, shape, and colour of lesions.2 Clinical features alone are insufficient for diagnosis and skin biopsy is mandatory.2 The most common histopathologic findings in MF are epidermotropism, followed by features of cerebriform nuclei, Pautrier abscesses and lymphocytic atypia.3 Massone et al also documented the presence of melanophages and extravasated erythrocytes in PPD-like MF.7 On immunohistochemistry, CD8+ T-cells are predominant in hypopigmented MF and younger patients, however CD4+ T-cells were more frequents associated with MF in older patients.4 Clonal rearrangement of the T-cell receptor can be helpful if histology is nonspecific.4 Diagnosis and management of MF is challenging. Definitive guidelines for management of mycosis fungoides in the paediatric population are lacking. For this reason, the multidisciplinary team approach is recommended to ensure a correct diagnosis and optimal treatment. MF is often diagnosed at an early stage (stage IA, IB, IIA) during childhood and the published literature recommends skin directed therapies, which include topical corticosteroids, topical vitamin D analogues, topical calcineurin inhibitors and phototherapy.2-4 Paediatric onset MF has a good prognosis and responds well to treatment; however, recurrences are frequent when treatment is discontinued which highlights the importance of maintenance therapy and long-term follow up. All authors contributed to the manuscript conception, design, and writing. All authors read and approved the final manuscript. The authors declare no conflict of interest. The parents/guardians of minor patient have given written informed consent for their child's participation in the study, as well as for the use of their child's deidentified, anonymized, aggregated data and case details (including photographs) for publication. Ethical Approval: not applicable Data sharing is not applicable to this article as no new data were created or analysed in this study
No takes yet. Share an insight, caveat, or question.
Grechin et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: